|
|
||||||||
Chain Following T Cell Stimulation with Analogue Peptides of Type II Collagen 2602671





Departments of
*
Medicine and
Pediatrics, University of Tennessee, Memphis, TN 38163; and
Veterans Affairs Medical Center, Memphis, TN 38104
The immunodominant T cell determinant of type II collagen (CII)
recognized by DBA/1 mice (I-Aq) is CII 260267. The
aims of this study were to determine the role of the amino acid
residues within CII 245270 in T cell signal transduction. To that
end, we utilized I-Aq-restricted, CII-specific T cell
hybridomas and examined tyrosine phosphorylation of TCR-
following
stimulation with either wild-type CII 245270 or a panel of analogue
peptides. A variety of patterns occurred, ranging from increased
phosphorylation of TCR-
to either partial or a complete abrogation
of phosphorylation. Critical substitutions also completely abrogated
the phosphorylation of ZAP70, a downstream molecule in TCR-
signaling. Evaluation of the supernatants of the T cell hybridomas for
cytokine production in response to the peptides revealed a close
correlation between the induction of phosphorylation of TCR-
and the
amount of cytokine induced. Selected analogue peptides were tested as
tolerogens in neonatal mice. Analogues that did not induce the
phosphorylation of
chain, such as B3 (CII 251270s263F
N), were
completely unable to induce tolerance, while analogues that caused a
partial phosphorylation, such as B6 (CII 251270s267Q
T) and A3 (CII
245270s269P
A), induced partial tolerance judged by intermediate
degrees of suppression of arthritis. We conclude that discrete
alterations in specific amino acid residues of antigenic peptides had
profound effects on T cell signaling and that the signaling correlated
with T cell cytokine secretion and T cell function in the induction of
tolerance and suppression of arthritis.
This article has been cited by other articles:
![]() |
B. Dzhambazov, K. S. Nandakumar, J. Kihlberg, L. Fugger, R. Holmdahl, and M. Vestberg Therapeutic Vaccination of Active Arthritis with a Glycosylated Collagen Type II Peptide in Complex with MHC Class II Molecules J. Immunol., February 1, 2006; 176(3): 1525 - 1533. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bouhdoud, P. Villain, A. Merzouki, M. Arella, and C. Couture T-Cell Receptor-Mediated Anergy of a Human Immunodeficiency Virus (HIV) gp120-Specific CD4+ Cytotoxic T-Cell Clone, Induced by a Natural HIV Type 1 Variant Peptide J. Virol., March 1, 2000; 74(5): 2121 - 2130. [Abstract] [Full Text] |
||||
![]() |
C. Maccalli, P. Pisarra, C. Vegetti, M. Sensi, G. Parmiani, and A. Anichini Differential Loss of T Cell Signaling Molecules in Metastatic Melanoma Patients' T Lymphocyte Subsets Expressing Distinct TCR Variable Regions J. Immunol., December 15, 1999; 163(12): 6912 - 6923. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Myers, B. Tang, E. F. Rosloniec, J. M. Stuart, T. M. Chiang, and A. H. Kang Characterization of a Peptide Analog of a Determinant of Type II Collagen That Suppresses Collagen-Induced Arthritis J. Immunol., October 1, 1998; 161(7): 3589 - 3595. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |